Langerhans Cell Histiocytosis in the Skull : Comparison of MR Image and Other Images
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose : To evaluate the characteristic MR imaging findings of Langerhans cell histiocytosis (LCH) in the skull and to compare them with those of plain radiography and computed tomography. Materials and Methods : A total of 10 lesions in 9 patients (Age range; 5-42 years, Mean age; 18, all women) with Langerhans cell histiocytosis in the skull were included in our study. Nine lesions in nine patients were histologically confirmed by surgery or fine needle aspiration biopsy. All patients performed with MRI, and plain radiography and CT scan were done in 7 patients (8 lesions). Two experienced neuroradiologists reviewed the radiological examinations independently with attention to location, size, shape and nature of the lesions in the skull and compared the extent and extension of the lesions to adjacent structures. Results : The lesions were distributed in all of the skulls without predilection site. On MRI, the masses were shown as well-enhancing soft tissue masses (10/10) mainly in diploic spaces (8/10) with extension to scalp (9/10) and dura mater (7/10). Dural enhancement (7/10) and thickening (4/10) were seen. The largest diameter of the soft tissue masses ranged 1.1 cm to 6.8 cm, shaped as round (5/10) or oval (5/10). On CT scans, the lesions were presented as soft tissue masses involving diploic space (6/8) and scalp extension (7/8) were also well visualized. Although bony erosion or destruction was more clearly seen on CT rather than those of MRI, enhancement of soft tissue masses and dura were not well visualized on CT. In contrast, all of the lesions in LCH were seen as punched out (4/8), beveled-edge appearance (4/8) osteolytic masses in plain radiography, but scalp and dural extension could not be seen. Conclusion : Characteristic MR findings in patients with LCH are soft tissue mass in diploic space with extension to dura and scalp, and MRI would be better imaging modality than plain radiography or CT.
Abstract
Purpose : To evaluate the characteristic MR imaging findings of Langerhans cell histiocytosis (LCH) in the skull and to compare them with those of plain radiography and computed tomography. Materials and Methods : A total of 10 lesions in 9 patients (Age range; 5-42 years, Mean age; 18, all women) with Langerhans cell histiocytosis in the skull were included in our study. Nine lesions in nine patients were histologically confirmed by surgery or fine needle aspiration biopsy. All patients performed with MRI, and plain radiography and CT scan were done in 7 patients (8 lesions). Two experienced neuroradiologists reviewed the radiological examinations independently with attention to location, size, shape and nature of the lesions in the skull and compared the extent and extension of the lesions to adjacent structures. Results : The lesions were distributed in all of the skulls without predilection site. On MRI, the masses were shown as well-enhancing soft tissue masses (10/10) mainly in diploic spaces (8/10) with extension to scalp (9/10) and dura mater (7/10). Dural enhancement (7/10) and thickening (4/10) were seen. The largest diameter of the soft tissue masses ranged 1.1 cm to 6.8 cm, shaped as round (5/10) or oval (5/10). On CT scans, the lesions were presented as soft tissue masses involving diploic space (6/8) and scalp extension (7/8) were also well visualized. Although bony erosion or destruction was more clearly seen on CT rather than those of MRI, enhancement of soft tissue masses and dura were not well visualized on CT. In contrast, all of the lesions in LCH were seen as punched out (4/8), beveled-edge appearance (4/8) osteolytic masses in plain radiography, but scalp and dural extension could not be seen. Conclusion : Characteristic MR findings in patients with LCH are soft tissue mass in diploic space with extension to dura and scalp, and MRI would be better imaging modality than plain radiography or CT.
참고문헌 (28)
- "A multicentre retrospective survey of Langerhans’ cell histiocytosis: 348 cases observed between 1983 and 1993: The French Langerhans’ Cell Histiocytosis Study Group", Arch Dis Child, 75, pp.17~24 (1996)
- Arceci RJ, "The histiocytoses: the fall of the Tower of Babel", Eur J Cancer, 35, pp.747~767 (1999)
- Ladisch S, "The histiocytoses", pp.491~504 (1989), Lippincott
- Leonidas JC, "Langerhans’ cell histiocytosis. In: Radiology: diagnosis, imaging, intervention. Vol 5", pp.1~9 (1990), Lippincott
- David R, "Radiologic features of eosinophilic granuloma of bone", AJR Am J Roentgenol, 153, pp.1021~1026 (1989)
- Mirra JM, "radiologic, and pathologic correlations. Vol 2", pp.1021~1060 (1989), Lea & Febiger
- Broadbent V, "Histiocytosis syndromes in children. II. Approach to the clinical and laboratory evaluation of children with Langerhans cell histiocytosis", Med Pediatr Oncol, 17, pp.492~495 (1989)
- Stull MA, "From the archives of the AFIP: Langerhans cell histiocytosis of bone", Radiographics, 12, pp.801~823 (1992)
- Rawlings CE 3rd, "Solitary eosinophilic granuloma of the skull", Neurosurgery, 15, pp.155~161 (1984)
- Favara BE, "Histiocytosis X", Hum Pathol, 14, pp.663~676 (1983)
- Favara BE, "Langerhans’ cell histiocytosis pathobiology and pathogenesis", Semin Oncol, 18, pp.3~7 (1991)
- Kilpatrick SE, "Langerhans’cell histiocytosis (histiocytosis X of bone)", Cancer, 76, pp.2471~2484 (1995)
- Al-Abbadi M, "Soft tissue Langerhans’ cell histiocytosis in an adult", Arch Pathol Lab Med, 121, pp.169~172 (1997)
- Schmitz L, "Nosology and pathology of Langerhans cell histiocytosis", Hematol Oncol Clin North Am, 12, pp.221~246 (1998)
- Brown RE, "Angiotensin-converting enzyme, transforming growth factor β1, and interleukin 11 in the osteolytic lesions of Langerhans cell histiocytosis", Arch Pathol Lab Med, 124, pp.1287~1290 (2000)
- Huang F, "The histiocytoses of infancy", Semin Perinatol, 23, pp.319~331 (1999)
- Howarth DM, "Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome", Cancer, 85, pp.2278~2290 (1999)
- Egeler RM, "Langerhans cell histiocytosis", JPediatr, 127, pp.1~11 (1995)
- Huvos AG, "Bone tumors", pp.695~771 (1991), Saunders
- Resnick D, "Lipidoses, histiocytoses, and hypenlipoproteinemias. in: Diagnosis ofbone and joint disorders. Vol 4. 2nd ed", pp.2429~2439 (1988), Saunders
- Prayer D, "MR imaging presentation of intracranial disease associated with Langerhans cell histiocytosis", AJNR Am J Neuroradiol, 25, pp.880~891 (2004)
- Azouz EM, "Langerhans’cell histiocytosis: pathology, imaging and treatment of skeletal involvement", Pediatr Radiol, 35(2), pp.103~15 (2005)
- Campanacci M, "Bone and soft tissue tumors, 2nd ed", pp.857~876 (1999), Springer
- Dorfman HD, "Bone tumors", pp.690~701 (1997), Mosby
- De Schepper AM, "MR imaging of eosinophilic granuloma: report of 11 cases", Skeletal Radiol, 22, pp.163~166 (1993)
- Kilborn TN, "Paediatric manifestations of Langerhans cell histiocytosis: a review of the clinical and radiological findings", Clin Radiol, 58(4), pp.269~278 (2003)
- Keyaki A, "Magnetic resonance imaging of calvarial eosinophilic granuloma with pericranial soft tissue reaction-case report", Neurol Med Chir, 40, pp.110~111 (2000)
- Wilner D, "Radiology of bone tumors and allied disorders", pp.1330~1435 (1982), Saunders